CVS Health Corporation (CVS) Shares Bought by Cambria Investment Management L.P.

Cambria Investment Management L.P. boosted its holdings in CVS Health Corporation (NYSE:CVS) by 1.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 17,548 shares of the pharmacy operator’s stock after acquiring an additional 214 shares during the period. Cambria Investment Management L.P.’s holdings in CVS Health Corporation were worth $1,378,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Bank of America Corp DE raised its stake in CVS Health Corporation by 1.8% in the 1st quarter. Bank of America Corp DE now owns 22,411,957 shares of the pharmacy operator’s stock valued at $1,759,338,000 after acquiring an additional 398,999 shares during the period. Pioneer Investment Management Inc. raised its stake in CVS Health Corporation by 4.6% in the 1st quarter. Pioneer Investment Management Inc. now owns 8,033,087 shares of the pharmacy operator’s stock valued at $630,598,000 after acquiring an additional 353,621 shares during the period. Parnassus Investments CA raised its stake in CVS Health Corporation by 2.9% in the 1st quarter. Parnassus Investments CA now owns 6,237,016 shares of the pharmacy operator’s stock valued at $473,605,000 after acquiring an additional 175,695 shares during the period. Legal & General Group Plc raised its stake in CVS Health Corporation by 5.3% in the 1st quarter. Legal & General Group Plc now owns 5,305,671 shares of the pharmacy operator’s stock valued at $416,484,000 after acquiring an additional 268,160 shares during the period. Finally, LSV Asset Management raised its stake in CVS Health Corporation by 44.2% in the 1st quarter. LSV Asset Management now owns 4,579,916 shares of the pharmacy operator’s stock valued at $359,523,000 after acquiring an additional 1,404,384 shares during the period. Institutional investors and hedge funds own 81.55% of the company’s stock.

CVS Health Corporation (NYSE:CVS) traded up 0.19% during mid-day trading on Monday, reaching $79.87. The company had a trading volume of 1,730,684 shares. CVS Health Corporation has a 12-month low of $69.30 and a 12-month high of $92.79. The stock has a market capitalization of $81.19 billion, a P/E ratio of 15.91 and a beta of 0.92. The stock has a 50 day moving average price of $78.37 and a 200-day moving average price of $78.91.

CVS Health Corporation (NYSE:CVS) last issued its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.31 by $0.02. The company had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. CVS Health Corporation’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.32 EPS. Equities analysts anticipate that CVS Health Corporation will post $5.88 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “CVS Health Corporation (CVS) Shares Bought by Cambria Investment Management L.P.” was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this piece of content can be read at https://sportsperspectives.com/2017/09/11/cvs-health-corporation-cvs-shares-bought-by-cambria-investment-management-l-p.html.

In other CVS Health Corporation news, EVP Helena Foulkes sold 20,332 shares of the company’s stock in a transaction that occurred on Monday, June 19th. The stock was sold at an average price of $76.98, for a total transaction of $1,565,157.36. Following the completion of the transaction, the executive vice president now owns 59,300 shares of the company’s stock, valued at approximately $4,564,914. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard J. Swift sold 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $79.62, for a total value of $199,050.00. Following the transaction, the director now directly owns 3,258 shares of the company’s stock, valued at approximately $259,401.96. The disclosure for this sale can be found here. Insiders have sold a total of 43,165 shares of company stock valued at $3,390,847 over the last 90 days. 0.61% of the stock is currently owned by company insiders.

A number of equities research analysts recently weighed in on the company. Needham & Company LLC restated a “hold” rating on shares of CVS Health Corporation in a research note on Sunday. BidaskClub cut CVS Health Corporation from a “hold” rating to a “sell” rating in a research report on Friday, August 25th. Loop Capital initiated coverage on CVS Health Corporation in a research report on Thursday, August 24th. They set a “hold” rating and a $83.00 price objective on the stock. Citigroup Inc. lowered their price objective on CVS Health Corporation from $88.00 to $87.00 and set a “neutral” rating on the stock in a research report on Thursday, August 17th. Finally, Robert W. Baird reiterated an “outperform” rating and set a $90.00 price objective on shares of CVS Health Corporation in a research report on Monday, August 14th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have issued a buy rating to the company. CVS Health Corporation has an average rating of “Buy” and a consensus target price of $90.83.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply